Cutaneous Manifestations of the COVID-19 Pandemic in Schoolchildren and Adolescents

    Daniela Franulić, Ena Parać, Lorena Dolački, Iva Topalušić, Liborija Lugović-Mihić
    Image of study
    TLDR The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.
    This review article highlights the skin issues faced by schoolchildren and adolescents aged 6 to 18 years during the COVID-19 pandemic, including those caused by personal protective equipment (PPE), SARS-CoV-2 infection, and the vaccine. Mask-related acne is prevalent due to microbiome changes and skin disruption. Infections can lead to chilblain-like lesions, erythema multiforme-like eruptions, and multisystem inflammatory syndrome, with a prevalence of cutaneous manifestations estimated between 0.25% and 3%. Hair and nail conditions such as alopecia areata and telogen effluvium have also been reported. Vaccine-related skin issues in children differ from adults, with cases of vitiligo, toxic epidermolysis, and alopecia areata noted. Chilblain-like lesions are the most common skin manifestation, occurring in 67.5% of cases, and may aid in early COVID-19 detection. No causal link between COVID vaccines and chilblain-like lesions has been confirmed, but isolated cases of alopecia and skin reactions post-vaccination have been observed. The review underscores the importance of recognizing these skin manifestations for early detection and management of COVID-19 in the pediatric population.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  11 upvotes 1 year ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

      community No idea what's causing my hair thinning

      in Chat  2 upvotes 1 month ago
      The user is experiencing diffuse hair thinning despite using finasteride and oral minoxidil, with no hairline recession or bald spots. Suggestions include checking for telogen effluvium, considering a JAK inhibitor for potential autoimmune issues, and conducting further tests to rule out other causes.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  37 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Related Research

    1 / 1 results